Assessing treatment benefit in the presence of placebo response using the sequential parallel comparison design-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Assessing treatment benefit in the presence of placebo response using the sequential parallel comparison design

Published:2022-02-20 Issue:12 Volume:41 Page:2166-2190
ISSN:0277-6715
Container-title:Statistics in Medicine
language:en
Short-container-title:Statistics in Medicine

Author:

Liu Xiaoyan¹^ORCID,Kim Chanmin¹²^ORCID,Han Zifei³^ORCID,Lim Pilar⁴,Roychoudhury Satrajit⁵^ORCID,Fava Maurizio⁶,Doros Gheorghe¹

Affiliation:

1. Department of Biostatistics Boston University Boston Massachusetts USA

2. Department of Statistics SungKyunKwan University Seoul Korea

3. School of Statistics University of International Business and Economics Beijing China

4. Janssen Research & Development LLC Raritan New Jersey USA

5. Pfizer Inc. New York New York USA

6. Massachusetts General Hospital and Harvard Medical School Boston Massachusetts USA

Funder

National Research Foundation of Korea

Publisher

Wiley

Subject

Statistics and Probability,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/sim.9349

Reference41 articles.

1. The placebo response in clinical trials: more questions than answers

2. Exploratory Analyses of Efficacy Data From Major Depressive Disorder Trials Submitted to the US Food and Drug Administration in Support of New Drug Applications

3. Placebo Response in Studies of Major Depression

4. The Problem of the Placebo Response in Clinical Trials for Psychiatric Disorders: Culprits, Possible Remedies, and a Novel Study Design Approach

5. Placebo non-response measure in sequential parallel comparison design studies

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP